Articles

Nebraska Medicine Now a Comprehensive Stroke Center

  William Thorell, MD, endovascular neurosurgeon Nebraska Medicine was recently certified as a Comprehensive Stroke Center by Joint Commission, in collaboration with the American Heart Association/American Stroke Association’s Brain Attack Coalition — the highest level of stroke certification available. This advanced designation by the nation’s largest independent health care evaluation body means that Nebraska Medicine is […]

Adult congenital heart disease program accredited

  Shane Tsai, M.D. In recognition of its expertise in serving adults with congenital heart disease (CHD), Nebraska Medicine and Children’s Hospital & Medical Center’s joint Adult Congenital Heart Disease (ACHD) program has received accreditation from the Adult Congenital Heart Association (ACHA), a nationwide organization focused on connecting patients, family members and health care providers […]

Promising New Cancer Treatment Offered at Nebraska Medicine is Approved by the FDA

Dr. Julie Vose visits with Amy Cheese during a clinic appointment at Nebraska Medicine in early 2017. When Amy first arrived, she had a tumor inside her chest the size of a grapefruit. Today, Amy is in remission and back to teaching.   It’s the fifth most common type of cancer in U.S. adults. For […]

Natural Killer (NK) Cell Therapy for Multiple Myeloma Patients

Sarah Holstein, MD, PhD While the outcomes of patients diagnosed with multiple myeloma have significantly improved, there continues to be a need for new therapeutic approaches. As is the case with many other cancers, there has been great interest in the possibility of harnessing the power of the immune system to attack the myeloma cells. […]

Nebraska Medicine and Children’s Earn Accreditation for Joint Adult Congenital Heart Disease (ACHD) Program

Home /Heart and Vascular /Adult Congenital Heart Disease /Nebraska Medicine and Children’s Earn Accreditation for Joint Adult Congenital Heart Disease (ACHD) Program Program is One of the First in the U.S. to Earn ACHA Accreditation In recognition of its expertise in serving adults with congenital heart disease (CHD), Nebraska Medicine and Children Hospital & Medical […]

Celebrating Elite National Quality Award, Again

Excellence Award from Vizient, Inc. for Quality Leadership Performance Nebraska Medical Center is again honored to announce its recognition by Vizient, Inc., as a recipient of the 2017 Bernard A. Birnbaum, MD, Quality Leadership Award. The award recognizes Nebraska Medical Center for demonstrating superior quality and safety performance among more than 100 academic medical centers […]

Dr. Wisecarver elected president of ASCP

James Wisecarver, M.D., Ph.D. James Wisecarver, M.D., Ph.D., has been elected president of the American Society for Clinical Pathology (ASCP). Dr. Wisecarver, who will serve a one-year term, assumed the presidency at the ASCP annual meeting held Sept. 6-8 in Chicago. Dr. Wisecarver serves as the vice chair for clinical affairs for the UNMC Department […]

Revolutionary Cancer Care that’s the Right Care for Your Patient

When you have a patient who has been diagnosed with cancer, you want to make sure he or she is not only receiving the best and most cutting-edge care, but also the right care. Roger Belohlavy is a case in point. Belohlavy was critically ill. All treatments for his acute lymphoblastic leukemia had failed. Until […]

Nebraska Medicine Earns Elite National Quality Award

Excellence Award from Vizient, Inc. for Quality Leadership Performance Nebraska Medicine is honored to announce its recognition by Vizient, Inc., as a recipient of the 2016 Bernard A. Birnbaum, MD Quality Leadership Award. The award recognizes Nebraska Medicine’s performance among more than 100 academic medical centers participating in Vizient’s Quality and Accountability Study. Thirteen academic […]

Study aims to improve pancreatic cancer therapies

by John Keenan, UNMC public relations Pankaj Singh, Ph.D. Pankaj Singh, Ph.D., professor in the Eppley Institute for Research in Cancer and Allied Diseases, is the corresponding author of a paper published this month in the journal “Cancer Cell.”Dr. Singh’s paper, “MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to […]

Articles Archive »

Loading